Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Epidemiology

Computer Science

Medicine

Immunology

Show all topics

DOI

10.1101/2023.11.22.567930

License

CC-BY-NC-ND

Other Formats

PDF